GRAS Notice 864, Bacillus Coagulans SNZ 1969 Spore Preparation

Total Page:16

File Type:pdf, Size:1020Kb

GRAS Notice 864, Bacillus Coagulans SNZ 1969 Spore Preparation GRAS Notice (GRN) No. 864 https://www.fda.gov/food/generally-recognized-safe-gras/gras-notice-inventory 749 46th Square Vero Beach, FL 32968, USA Telephone: 772-299-0746 Soni & Associates Inc. Facsimile: 772-299-5381 E-mail: [email protected] May 21, 2019 Food and Drug Administration Center for Food Safety and Applied Nutrition Office of Food Additive Safety (HFS-200) 5100 Campus Drive College Park, MD 20740 Subject: GRAS Notification for the intended use of Bacillus coagulans SNZ 1969 spores preparation in Infant Formula Dear Sir/Madam: In accordance with 21 CFR part 170, subpart E, Sanzyme Biologics Pvt. Ltd., through Soni & Associates Inc. as its agent, hereby submits the enclosed notice of a claim that the food ingredient Bacillus coagulans SNZ 1969 spores preparation for use in infant formula as described in the enclosed notification document is exempt from the premarket approval requirement of the Federal Fo~ Drug, and Cosmetic Act because it has been determined to be Generally Recognized As Safe (GRAS), based on scientific procedures. As required, please find enclosed three copies of the notification. If you have any questions or require additional information, please feel free to contact me by phone at + 1-772- 299-0746 or by email at [email protected]. Sincerely, _ - Madhu G. Soni, PhD, FACN, FATS Agent for Sanzyme Biologics Pvt. Ltd. INDIA Enclosure: Three copies of GRAS notification www .soniassociates.net GENERALLY RECOGNIZED AS SAFE (GRAS) EVALUATION OF BACILLUS COAGULANS SNZ 1969 FOR USES IN TERM INFANT FORMULA Submitted by: Sanzyme Biologics Pvt. Limited Plot No. 13, Sagar Society Banjara Hills, Road Number 2 Hyderabad - 500 034, Telengana INDIA Submitted to: U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition Office of Food Additive Safety HFS-200 5100 Campus Drive College Park, MD 20740 USA Contact for Technical and Other Information Madhu G. Soni, PhD Soni & Associates Inc. 749 46th Square Vero Beach, FL 32968 May 08, 2019 GENERALLY RECOGNIZED AS SAFE (GRAS) EVALUATION OF Bacillus coagulans SNZ 1969 FOR USES IN TERM INFANT FORMULA TABLE OF CONTENTS 1. Part 1.- SIGNED STATEMENTS AND CERTIFICATION .... ;.......................................... 4 1.1. Name and Address of Notifier ...................................................................................... 4 1.2. Name of Notified Substance .......................................................................................... 4 1.3. Intended Conditions of Use ........................................................................................... 4 1.4. Statutory Basis for GRAS Determination ................................................................... 5 1.5. Exclusion from Premarket Approval ........................................................................... 5 1.6. Availability of Data & Information .............................................................................. 5 1. 7. Data Exemption from Disclosure ................................................................................. 5 1.8. Certification .................................................................................................................... 6 1.9. Name, Position/Title of Responsible Person who Signs the Dossier and Signature. 6 1.10. FSIS/USDA - Use in Meat and/or Poultry .................................................................. 6 2. Part 2 -IDENTITY, SPECIFICATION AND MANUFACTURING ................................. 7 2.1. Identity ............................................................................................................................ 7 2.1.1. Name and Source of GRAS Organism ......................................................................... 7 2.1.2. Description of GRAS Organism ................................................................................... 7 2.1.3. Identification and Characterization ............................................................................. 8 2.1.3.1. Phenotypic Identification .............................................................................................. 8 2.1.3.2. Genotypic Identification ................................................................................................ 9 2.1.3.2.1. Genomic DNA isolation and quality assessment. ....................................................... 9 2.1.3.2.2. rRNA gene PCR and phylogenetic analysis ............................................................... 9 2.1.3.2.3. Whole Genome Sequencing ........................................................................................ 11 2.1.4. Manufacturing Process ................................................................................................ 12 2.1.4.1. Seed Media Preparation .............................................................................................. 12 2.1.4.2. Seed Inoculation and Culture Growth ....................................................................... 12 2.1.4.3. Sterilization, Fermentation and Separation .............................................................. 13 2.1.4.4. Drying, Sifting, Blending, Packaging ......................................................................... 13 Sanzyme Page 2 of60 B. coagu/ans GRAS-IF 2.2. Specifications···················.····························································································· 14 3. Part III - DIETARY EXPOSURE ....•............•............•...........•...........•......•.............•......••.... 16 3.1. Intended Use Levels and Food Categories ................................................................. 16 3.1.1. Estimated Daily Intake from the Proposed Uses ...................................................... 16 4. Part IV - SELF LIMITING LEVELS OF USE ................................................................... 18 5. Part V - EXPERIENCE BASED ON COMMON USE IN FOODS BEFORE 1958 ....... 19 6. Part VI - NARRATIVE ........•............•.•.......................•...........•........•.........•.......•.....•.•........•. 20 6.1. Data Pertaining to Safe Uses .............•........•........................•..•..........•...............•...•.•... 20 6.1.1. Traditional Uses .........•................•........•......••...•..................•............................•.....•..... 20 6.1.2. Current Uses and Regulatory Status.......................................................................... 20 6.2. Safety Related Studies ..•.•...............................................•........................•...........•....... 23 6.2.1. Studies in Infants and Children •..•..•........•••...•.•..•.•.•.••.....•....•..•.••.•.•.•...•.••••.•......••.•.••• 23 6.2.2. Human Studies with Labcon (Mother strain of SNZ 1969) ..................................... 26 6.2.3. Studies in Adult Human Subjects .••.•........•......•.......•.•••.....••.•...•••....•.••.•••.•.•.......•....•.. 27 6.2.4. Safety Based on Genome Sequencing......................................................................... 35 6.2.5. Specific Antibiotic Susceptibility Studies .................................................................. 36 6.2.6. Specific Antimicrobial Action Studies ....................................................................... 37 6.2.7. Specific Bile Salt and Acid Tolerance Studies ........................................................... 38 6.2.8. Animal Toxicity Studies .............•.....................................••.....•.........•.............•.•........•. 38 6.3. Expert Panel Review, Summary and Discussion ...................................................... 44 6.4. Expert Panel Conclusion ..................................................•......................................•... 48 7. Part VII - SUPPORTING DATA AND INFORMATION ................................................. 49 Sanzyme Page 3 of60 B. coagu/ans GRAS-IF 1. Part I - SIGNED STATEMENTS AND CERTIFICATION 1.1. Submission of GRAS Notice In accordance with 21 CFR § 170 Subpart E consisting of§ 170.203 through § 170.285, Sanzyme Biologics Pvt. Ltd., (Sanzyme Biologics) hereby informs the FDA that Bacillus coagulans SNZ 1969 spores preparations manufactured by Sanzyme Biologics, is not subject to the premarket approval requirements of the Federal Food, Drug, and Cosmetic Act based on Sanzyme Biologics' view that the notified substance is Generally Recognized as Safe (GRAS) under the conditions of its intended use described in Section 1.3 below. It should be noted that the subject of the present GRAS assessment, B. coagulans SNZ 1969 spore preparation, for use in term infant formula is identical to that of Sanzyme Ltd. 1 (the parent company Sanzyme Biologics) GRAS notice (GRN 597) that received a "no question letter" from FDA for the use of Bacillus coagulans SNZ 1969 spores preparation in conventional foods. 1.2. Name and Address of Notifier Sanzyme Biologics Pvt. Limited Plot No. 13, Sagar Society Banjara Hills, Road Number 2 Hyderabad - 500 034, Telengana INDIA 1.3. Name of Notified Substance The common name of the substance of this GRAS assessment is Bacillus coagulans SNZ 1969 spores preparation for uses in term infant formula will be marketed as standardized powder. 1.4. Intended Conditions of Use Bacillus coagulans SNZ 1969 spore preparation (B. coagulans) is intended for use as an ingredient in non-exempt term infant formula at the maximum intended addition levels of 2xl 08 colony forming units (cfu) per 100 mL infant formula as ready for consumption. B. coagulans is not intended for addition
Recommended publications
  • Consolidated Version of the Sanpin 2.3.2.1078-01 on Food, Raw Material, and Foodstuff
    Registered with the Ministry of Justice of the RF, March 22, 2002 No. 3326 MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION CHIEF STATE SANITARY INSPECTOR OF THE RUSSIAN FEDERATION RESOLUTION No. 36 November 14, 2001 ON ENACTMENT OF SANITARY RULES (as amended by Amendments No.1, approved by Resolution No. 27 of Chief State Sanitary Inspector of the RF dated 20.08.2002, Amendments and Additions No. 2, approved by Resolution No. 41 of Chief State Sanitary Inspector of the RF dated15.04.2003, No. 5, approved by Resolution No. 42 of Chief State Sanitary Inspector of the RF dated 25.06.2007, No. 6, approved by Resolution No. 13 of Chief State Sanitary Inspector of the RF dated 18.02.2008, No. 7, approved by Resolution No. 17 of Chief State Sanitary Inspector of the RF dated 05.03.2008, No. 8, approved by Resolution No. 26 of Chief State Sanitary Inspector of the RF dated 21.04.2008, No. 9, approved by Resolution No. 30 of Chief State Sanitary Inspector of the RF dated 23.05.2008, No. 10, approved by Resolution No. 43 of Chief State Sanitary Inspector of the RF dated 16.07.2008, Amendments No.11, approved by Resolution No. 56 of Chief State Sanitary Inspector of the RF dated 01.10.2008, No. 12, approved by Resolution No. 58 of Chief State Sanitary Inspector of the RF dated 10.10.2008, Amendment No. 13, approved by Resolution No. 69 of Chief State Sanitary Inspector of the RF dated 11.12.2008, Amendments No.14, approved by Resolution No.
    [Show full text]
  • Characterisation of Bacteria Isolated from the Stingless Bee, Heterotrigona Itama, Honey, Bee Bread and Propolis
    Characterisation of bacteria isolated from the stingless bee, Heterotrigona itama, honey, bee bread and propolis Mohamad Syazwan Ngalimat1,2,*, Raja Noor Zaliha Raja Abd. Rahman1,2, Mohd Termizi Yusof2, Amir Syahir1,3 and Suriana Sabri1,2,* 1 Enzyme and Microbial Technology Research Center, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia 2 Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia 3 Department of Biochemistry, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia * These authors contributed equally to this work. ABSTRACT Bacteria are present in stingless bee nest products. However, detailed information on their characteristics is scarce. Thus, this study aims to investigate the characteristics of bacterial species isolated from Malaysian stingless bee, Heterotrigona itama, nest products. Honey, bee bread and propolis were collected aseptically from four geographical localities of Malaysia. Total plate count (TPC), bacterial identification, phenotypic profile and enzymatic and antibacterial activities were studied. The results indicated that the number of TPC varies from one location to another. A total of 41 different bacterial isolates from the phyla Firmicutes, Proteobacteria and Actinobacteria were identified. Bacillus species were the major bacteria found. Therein, Bacillus cereus was the most frequently isolated species followed by
    [Show full text]
  • Common Commensals
    Common Commensals Actinobacterium meyeri Aerococcus urinaeequi Arthrobacter nicotinovorans Actinomyces Aerococcus urinaehominis Arthrobacter nitroguajacolicus Actinomyces bernardiae Aerococcus viridans Arthrobacter oryzae Actinomyces bovis Alpha‐hemolytic Streptococcus, not S pneumoniae Arthrobacter oxydans Actinomyces cardiffensis Arachnia propionica Arthrobacter pascens Actinomyces dentalis Arcanobacterium Arthrobacter polychromogenes Actinomyces dentocariosus Arcanobacterium bernardiae Arthrobacter protophormiae Actinomyces DO8 Arcanobacterium haemolyticum Arthrobacter psychrolactophilus Actinomyces europaeus Arcanobacterium pluranimalium Arthrobacter psychrophenolicus Actinomyces funkei Arcanobacterium pyogenes Arthrobacter ramosus Actinomyces georgiae Arthrobacter Arthrobacter rhombi Actinomyces gerencseriae Arthrobacter agilis Arthrobacter roseus Actinomyces gerenseriae Arthrobacter albus Arthrobacter russicus Actinomyces graevenitzii Arthrobacter arilaitensis Arthrobacter scleromae Actinomyces hongkongensis Arthrobacter astrocyaneus Arthrobacter sulfonivorans Actinomyces israelii Arthrobacter atrocyaneus Arthrobacter sulfureus Actinomyces israelii serotype II Arthrobacter aurescens Arthrobacter uratoxydans Actinomyces meyeri Arthrobacter bergerei Arthrobacter ureafaciens Actinomyces naeslundii Arthrobacter chlorophenolicus Arthrobacter variabilis Actinomyces nasicola Arthrobacter citreus Arthrobacter viscosus Actinomyces neuii Arthrobacter creatinolyticus Arthrobacter woluwensis Actinomyces odontolyticus Arthrobacter crystallopoietes
    [Show full text]
  • WO 2013/116261 A2 8 August 2013 (08.08.2013) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/116261 A2 8 August 2013 (08.08.2013) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every CUD 3/386 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/US2013/023728 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, 30 January 2013 (30.01 .2013) KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (25) Filing Language: English NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, (26) Publication Language: English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (30) Priority Data: ZM, ZW. 12000745.5 3 February 2012 (03.02.2012) EP 12001034.3 16 February 2012 (16.02.2012) EP (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant: THE PROCTER & GAMBLE COMPANY GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, [US/US]; One Procter & Gamble Plaza, Cincinnati, Ohio UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 45202 (US).
    [Show full text]
  • Food Waste Composting and Microbial Community Structure Profiling
    processes Review Food Waste Composting and Microbial Community Structure Profiling Kishneth Palaniveloo 1,* , Muhammad Azri Amran 1, Nur Azeyanti Norhashim 1 , Nuradilla Mohamad-Fauzi 1,2, Fang Peng-Hui 3, Low Hui-Wen 3, Yap Kai-Lin 3, Looi Jiale 3, Melissa Goh Chian-Yee 3, Lai Jing-Yi 3, Baskaran Gunasekaran 3,* and Shariza Abdul Razak 4,* 1 Institute of Ocean and Earth Sciences, Institute for Advanced Studies Building, University of Malaya, Wilayah Persekutuan Kuala Lumpur 50603, Malaysia; [email protected] (M.A.A.); [email protected] (N.A.N.) 2 Institute of Biological Sciences, Faculty of Science, University of Malaya, Wilayah Persekutuan Kuala Lumpur 50603, Malaysia; [email protected] 3 Faculty of Applied Science, UCSI University (South Wing), Cheras, Wilayah Persekutuan Kuala Lumpur 56000, Malaysia; [email protected] (F.P.-H.); [email protected] (L.H.-W.); [email protected] (Y.K.-L.); [email protected] (L.J.); [email protected] (M.G.C.-Y.); [email protected] (L.J.-Y.) 4 Nutrition and Dietetics Program, School of Health Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia * Correspondence: [email protected] (K.P.); [email protected] (B.G.); [email protected] (S.A.R.); Tel.: +60-3-7967-4640 (K.P.); +60-16-323-4159 (B.G.); +60-19-964-4043 (S.A.R.) Received: 20 May 2020; Accepted: 16 June 2020; Published: 22 June 2020 Abstract: Over the last decade, food waste has been one of the major issues globally as it brings a negative impact on the environment and health.
    [Show full text]
  • Super Greens
    SUPER GREENS SUPPLEMENT FACTS Serving Size: 1 Scoop (10 g) Servings Per Container: 30 Amount Per Serving % Daily Value Calories 25 Total Carbohydrate 6 g 2%* Dietary Fiber 3 g 12%* Sugars 1 g † Protein <1 g <2%* Organic Super Greens, Sprouts & Prebiotic Fiber Blend: 3.5 g Wheat grass, barley grass, spirulina (blue green algae), green pea fiber, oat fiber, flaxseed, blue agave inulin, plum, orange peel, apple fiber, lemon peel, kale, broccoli, spinach, parsley, green cabbage, alfalfa grass, chlorella, green tea, tomato, sweet potato, pumpkin, dandelion root, collard greens, dulse, adzuki sprout, amaranth sprout, buckwheat sprout, chia sprout, flax sprout, garbanzo bean sprout, lentil bean sprout, millet sprout, pumpkin sprout, quinoa sprout, sesame sprout, sunflower sprout Organic Super Foods & Fruits Blend: 3.5 g Beet root, carrot, Organic Berry Blend [acai berry (Euterpe oleracea), apple, banana, bilberry, black currant, blueberry, cherry, elderberry, goji berry (Lycium barbarum), grape, maqui berry (Aristotelia chilensis), papaya, pineapple, pomegranate, raspberry, strawberry], apple, shitake mushroom, reishi mushroom, maitake mushroom, blueberry, raspberry, strawberry, peach, blackberry, lemon, pear, cranberry, grape, pomegranate, cherry, orange Probiotic Blend: 500 million CFU Bacillus coagulans, Lactobacillus rhamnosus, Bifidobacterium bifidum, Bifidobacterium longum, Lactobacillus acidophilus, Lactobacillus casei, Streptococcus thermophilus * Percent Daily Values are based on a 2,000 calorie diet. † Daily value not established. Other ingredients: Organic tapioca starch, organic guar gum, citric acid, organic natural berry flavor and organic rebaudioside A. .
    [Show full text]
  • Mai Muun Muntant Un an to the Man Uniti
    MAIMUUN MUNTANTUS009855303B2 UN AN TO THEMAN UNITI (12 ) United States Patent ( 10 ) Patent No. : US 9 , 855 ,303 B2 McKenzie et al. (45 ) Date of Patent: * Jan . 2 , 2018 ( 54 ) COMPOSITIONS AND METHODS (58 ) Field of Classification Search ??? . A61K 35 / 742 (71 ) Applicant : SERES THERAPEUTICS , INC . , See application file for complete search history . Cambridge, MA (US ) (72 ) Inventors : Gregory McKenzie , Arlington , MA ( 56 ) References Cited (US ) ; Mary - Jane Lombardo McKenzie , Arlington , MA (US ) ; David U . S . PATENT DOCUMENTS N . Cook , Brooklyn , NY (US ) ; Marin 3 ,009 , 864 A 11 / 1961 Gordon - Aldterton et al. Vulic , Boston , MA (US ) ; Geoffrey von 3 ,228 , 838 A 1 / 1966 Rinfret Maltzahn , Boston , MA (US ) ; Brian 3 ,608 ,030 A 9 / 1971 Tint Goodman , Boston , MA (US ) ; John 4 ,077 , 227 A 3 / 1978 Larson Grant Aunins , Doylestown , PA (US ) ; 4 , 205 , 132 A 5 / 1980 Sandine Matthew R . Henn , Somerville , MA 4 ,655 ,047 A 4 / 1987 Temple (US ) ; David Arthur Berry , Brookline , 4 ,689 , 226 A 8 / 1987 Nurmi MA (US ) ; Jonathan Winkler , Boston , 4 ,839 , 281 A 6 / 1989 Gorbach et al . 5 , 196 , 205 A 3 / 1993 Borody MA (US ) 5 , 425 , 951 A 6 / 1995 Goodrich 5 ,436 ,002 A 7 / 1995 Payne ( 73 ) Assignee : Seres Therapeutics , Inc ., Cambridge , 5 ,443 ,826 A 8 / 1995 Borody MA (US ) 5 , 599 , 795 A 2 / 1997 McCann 5 ,648 ,206 A 7 / 1997 Goodrich ( * ) Notice : Subject to any disclaimer , the term of this 5 , 951 , 977 A 9 / 1999 Nisbet et al. patent is extended or adjusted under 35 5 , 965 , 128 A 10 / 1999 Doyle et al .
    [Show full text]
  • AFS – Advances in Food Sciences Continuation of CMTL Founded by F
    AFS – Advances in Food Sciences Continuation of CMTL founded by F. Drawert Production by PSP – Parlar Scientific Publications, Angerstr. 12, 85354 Freising, Germany in cooperation with Lehrstuhl für Chemisch-Technische Analyse und Lebensmitteltechnologie, Technische Universität München, 85350 Freising - Weihenstephan, Germany Copyright © by PSP – Parlar Scientific Publications, Angerstr. 12, 85354 Freising, Germany. All rights are reserved, especially the right to translate into foreign language. No part of the journal may be reproduced in any form- through photocopying, microfilming or other processes- or converted to a machine language, especially for data processing equipment- without the written permission of the publisher. The rights of reproduction by lecture, radio and television transmission, magnetic sound recording or similar means are also reserved. Printed in GERMANY – ISSN 14311431----77377737 © by PSP Volume 24 – No 4. 2002 Advances in Food Sciences 1 © by PSP Volume 24 – No 4. 2002 Advances in Food Sciences AFSAFS---- Editorial Board Chief Editors: Prof. Dr. H. Parlar Institut für Lebensmitteltechnologie und Analytische Chemie, TU München - 85350 Freising-Weihenstephan, Germany - E-mail: [email protected] Dr. G. Leupold Institut für Lebensmitteltechnologie und Analytische Chemie, TU München - 85350 Freising-Weihenstephan, Germany - E-mail: [email protected] CoCo----Editor:Editor: Prof. Dr. R. G. Berger Zentrum Angewandte Chemie, Institut für Lebensmittelchemie, Universität Hannover Wunstorfer Straße 14, 30453 Hannover - E-mail: [email protected] AFSAFS- Advisory Board E. Anklam, I M. Bahadir, D F. Coulston, USA J.M. de Man, CAN N. Fischer, D S. Gäb, D A. Görg, D U. Gill, CAN D. Hainzl, P W.P. Hammes, D D. Kotzias, I F.
    [Show full text]
  • Public Health Impact a Suitable Test for L-Citrulline—
    1 Winter 2016 Public Health Impact A Suitable Test for L-citrulline— How Validated Test Methods May New Dietary Supplements Impact Public Health Reference Standards In the U.S., most newborn babies are screened for rare inborn errors of Below is a list of newly released metabolism (IEM)—a group of genetic disorders caused by a defect in a reference standards: metabolic pathway. Left untreated, these disorders can lead to a host of Botanicals medical and developmental consequences ranging from intellectual 1 disability to severe cognitive impairment and even death. • 2,3,5,4’-Tetrahydroxystilbebe-2- Some of these metabolic errors require the use of amino acids to avoid O-Beta-D-Glucoside the buildup of ammonia in the body. L-citrulline is one such amino acid, • Emodin and it is used for IEM as a medical food, which is regulated by the U.S. Food and Drug Administration (FDA) under the Orphan Drug Act. Medical • Polygonum multiflorum Root Dry foods are distinct within the broader category of foods and need to be Extract administered under the supervision of a healthcare professional • Lonicera japonica Flower Dry specifically to help manage a disease or condition associated with Extract distinctive nutritional requirements. In addition to being marketed as a medical food for IEM, L-citrulline is marketed as a dietary supplement for • Secoxyloganin other purposes. • Lonicera macranthoides Flower Sometimes, the quality control testing done to authenticate ingredients is Dry Extract insufficient to guarantee their quality. That was the case with L-citrulline in Luteolin-7-O-glucoside 2014. • One of the primary suppliers of the ingredient for use as a medical food voluntarily recalled several batches of the product after the FDA warned Non-Botanicals that the product being sold had no L-citrulline present.
    [Show full text]
  • Dietary Supplements Compendium Volume 1
    2015 Dietary Supplements Compendium DSC Volume 1 General Notices and Requirements USP–NF General Chapters USP–NF Dietary Supplement Monographs USP–NF Excipient Monographs FCC General Provisions FCC Monographs FCC Identity Standards FCC Appendices Reagents, Indicators, and Solutions Reference Tables DSC217M_DSCVol1_Title_2015-01_V3.indd 1 2/2/15 12:18 PM 2 Notice and Warning Concerning U.S. Patent or Trademark Rights The inclusion in the USP Dietary Supplements Compendium of a monograph on any dietary supplement in respect to which patent or trademark rights may exist shall not be deemed, and is not intended as, a grant of, or authority to exercise, any right or privilege protected by such patent or trademark. All such rights and privileges are vested in the patent or trademark owner, and no other person may exercise the same without express permission, authority, or license secured from such patent or trademark owner. Concerning Use of the USP Dietary Supplements Compendium Attention is called to the fact that USP Dietary Supplements Compendium text is fully copyrighted. Authors and others wishing to use portions of the text should request permission to do so from the Legal Department of the United States Pharmacopeial Convention. Copyright © 2015 The United States Pharmacopeial Convention ISBN: 978-1-936424-41-2 12601 Twinbrook Parkway, Rockville, MD 20852 All rights reserved. DSC Contents iii Contents USP Dietary Supplements Compendium Volume 1 Volume 2 Members . v. Preface . v Mission and Preface . 1 Dietary Supplements Admission Evaluations . 1. General Notices and Requirements . 9 USP Dietary Supplement Verification Program . .205 USP–NF General Chapters . 25 Dietary Supplements Regulatory USP–NF Dietary Supplement Monographs .
    [Show full text]
  • Ep 2434019 A1
    (19) & (11) EP 2 434 019 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 28.03.2012 Bulletin 2012/13 C12N 15/82 (2006.01) C07K 14/395 (2006.01) C12N 5/10 (2006.01) G01N 33/50 (2006.01) (2006.01) (2006.01) (21) Application number: 11160902.0 C07K 16/14 A01H 5/00 C07K 14/39 (2006.01) (22) Date of filing: 21.07.2004 (84) Designated Contracting States: • Kamlage, Beate AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 12161, Berlin (DE) HU IE IT LI LU MC NL PL PT RO SE SI SK TR • Taman-Chardonnens, Agnes A. 1611, DS Bovenkarspel (NL) (30) Priority: 01.08.2003 EP 03016672 • Shirley, Amber 15.04.2004 PCT/US2004/011887 Durham, NC 27703 (US) • Wang, Xi-Qing (62) Document number(s) of the earlier application(s) in Chapel Hill, NC 27516 (US) accordance with Art. 76 EPC: • Sarria-Millan, Rodrigo 04741185.5 / 1 654 368 West Lafayette, IN 47906 (US) • McKersie, Bryan D (27) Previously filed application: Cary, NC 27519 (US) 21.07.2004 PCT/EP2004/008136 • Chen, Ruoying Duluth, GA 30096 (US) (71) Applicant: BASF Plant Science GmbH 67056 Ludwigshafen (DE) (74) Representative: Heistracher, Elisabeth BASF SE (72) Inventors: Global Intellectual Property • Plesch, Gunnar GVX - C 6 14482, Potsdam (DE) Carl-Bosch-Strasse 38 • Puzio, Piotr 67056 Ludwigshafen (DE) 9030, Mariakerke (Gent) (BE) • Blau, Astrid Remarks: 14532, Stahnsdorf (DE) This application was filed on 01-04-2011 as a • Looser, Ralf divisional application to the application mentioned 13158, Berlin (DE) under INID code 62.
    [Show full text]
  • International Journal of Food Microbiology Occurrence Of
    International Journal of Food Microbiology 305 (2019) 108251 Contents lists available at ScienceDirect International Journal of Food Microbiology journal homepage: www.elsevier.com/locate/ijfoodmicro Occurrence of bacteria and endotoxins in fermented foods and beverages T from Nigeria and South Africa ⁎ Ifeoluwa Adekoyaa, , Adewale Obadinab, Momodu Olorunfemic, Olamide Akanded, Sofie Landschoote, Sarah De Saegerf, Patrick Njobeha a Department of Biotechnology and Food Technology, University of Johannesburg, Johannesburg, South Africa b Department of Food Science and Technology, Federal University of Agriculture, Abeokuta, Nigeria. c Department of Botany, University of Ibadan, Ibadan, Nigeria d Department of Food Science and Technology, Federal University of Technology, Akure, Nigeria e Department of Applied Bioscience Engineering, Ghent University, B-9000, Belgium f Centre of Excellence in Mycotoxicology and Public Health, Ghent University, B-9000, Belgium ARTICLE INFO ABSTRACT Keywords: In Africa, fermented foods and beverages play significant roles in contributing to food security. Endotoxins are Fermented foods ubiquitous heat stable lipopolysaccharide (LPS) complexes situated in the outer cell membranes of Gram-ne- Gram-negative bacteria gative bacteria. This study evaluated the microbiological quality of fermented foods (ogiri, ugba, iru, ogi and ogi Endotoxins baba) and beverages (mahewu and umqombothi) from selected Nigerian and South African markets. The bacterial Safety diversity of the fermented foods was also investigated and the identity of the isolates confirmed by biochemical Nigeria and molecular methods. Isolate grouping was established through hierarchal clustering and the samples were South Africa further investigated for endotoxin production with the chromogenic Limulus Amoebocyte Lysate assay. The total aerobic count of the samples ranged from 5.7 to 10.8 Log CFU/g.
    [Show full text]